Selective activation of peripheral blood T cell subsets by endotoxin infusion in healthy human subjects corresponds to differential chemokine activation.

PubWeight™: 0.96‹?› | Rank: Top 15%

🔗 View Article (PMID 16237112)

Published in J Immunol on November 01, 2005

Authors

Asit K De1, Carol L Miller-Graziano, Steve E Calvano, Krzysztof Laudanski, Stephen F Lowry, Lyle L Moldawer, Daniel G Remick, Natasa Rajicic, David Schoenfeld, Ronald G Tompkins

Author Affiliations

1: Department of Surgery, University of Rochester Medical Center, Rochester, NY 14627, USA.

Associated clinical trials:

Inflammation and the Host Response to Injury (Trauma) | NCT00257231

Articles by these authors

Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med (2000) 48.03

Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature (2007) 19.33

Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A (2013) 16.74

Detection of mutations in EGFR in circulating lung-cancer cells. N Engl J Med (2008) 13.54

A network-based analysis of systemic inflammation in humans. Nature (2005) 12.60

Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med (2004) 11.78

Translating the A1C assay into estimated average glucose values. Diabetes Care (2008) 11.55

Significance analysis of time course microarray experiments. Proc Natl Acad Sci U S A (2005) 8.65

Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. N Engl J Med (2006) 7.97

A genomic storm in critically injured humans. J Exp Med (2011) 6.67

MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis. J Exp Med (2007) 5.48

Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clin Infect Dis (2002) 5.34

Randomized, placebo-controlled clinical trial of an aerosolized β₂-agonist for treatment of acute lung injury. Am J Respir Crit Care Med (2011) 5.24

Trial of short-course antimicrobial therapy for intraabdominal infection. N Engl J Med (2015) 5.21

Continuous inertial focusing, ordering, and separation of particles in microchannels. Proc Natl Acad Sci U S A (2007) 4.44

Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer. Sci Transl Med (2010) 3.90

Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J Immunol (2006) 3.75

L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials. Am J Psychiatry (2012) 3.73

Application of genome-wide expression analysis to human health and disease. Proc Natl Acad Sci U S A (2005) 3.49

Analysis of Pseudomonas aeruginosa 4-hydroxy-2-alkylquinolines (HAQs) reveals a role for 4-hydroxy-2-heptylquinoline in cell-to-cell communication. Proc Natl Acad Sci U S A (2004) 3.30

Whole blood and leukocyte RNA isolation for gene expression analyses. Physiol Genomics (2004) 3.22

The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis. Nat Med (2011) 3.16

Support of the metabolic response to burn injury. Lancet (2004) 3.06

Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet Neurol (2010) 2.91

A microfluidic device for practical label-free CD4(+) T cell counting of HIV-infected subjects. Lab Chip (2006) 2.89

Effect of flow and surface conditions on human lymphocyte isolation using microfluidic chambers. Langmuir (2004) 2.76

Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J Infect Dis (2002) 2.76

American Burn Association consensus conference to define sepsis and infection in burns. J Burn Care Res (2007) 2.71

Increased cardiovascular disease risk indices in HIV-infected women. J Acquir Immune Defic Syndr (2005) 2.63

Effects of recruitment maneuvers in patients with acute lung injury and acute respiratory distress syndrome ventilated with high positive end-expiratory pressure. Crit Care Med (2003) 2.63

Abandon the mouse research ship? Not just yet! Shock (2014) 2.60

The pathogenesis of sepsis. Annu Rev Pathol (2011) 2.55

Quantitative proteome analysis of human plasma following in vivo lipopolysaccharide administration using 16O/18O labeling and the accurate mass and time tag approach. Mol Cell Proteomics (2005) 2.50

Mesenchymal stem cells: Mechanisms of immunomodulation and homing. Cell Transplant (2010) 2.50

Acute inflammatory response to endotoxin in mice and humans. Clin Diagn Lab Immunol (2005) 2.47

An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study. Lancet Neurol (2013) 2.43

The Drosophila melanogaster toll pathway participates in resistance to infection by the gram-negative human pathogen Pseudomonas aeruginosa. Infect Immun (2003) 2.41

Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis. Arch Gen Psychiatry (2005) 2.35

Structural basis for the proinflammatory cytokine activity of high mobility group box 1. Mol Med (2003) 2.30

Beyond mortality: future clinical research in acute lung injury. Am J Respir Crit Care Med (2010) 2.28

High dynamic range characterization of the trauma patient plasma proteome. Mol Cell Proteomics (2006) 2.25

Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care. J Trauma Acute Care Surg (2012) 2.24

Humane endpoints in shock research. Shock (2004) 2.18

Anti-TNF-alpha therapies: the next generation. Nat Rev Drug Discov (2003) 2.18

The changing pattern and implications of multiple organ failure after blunt injury with hemorrhagic shock. Crit Care Med (2012) 2.17

Equilibrium separation and filtration of particles using differential inertial focusing. Anal Chem (2008) 2.13

Comparison of analysis approaches for phase III clinical trials in amyotrophic lateral sclerosis. Muscle Nerve (2012) 2.13

A microchip approach for practical label-free CD4+ T-cell counting of HIV-infected subjects in resource-poor settings. J Acquir Immune Defic Syndr (2007) 2.08

Homocysteine mediated expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human monocytes. Circ Res (2003) 2.07

Benchmarking outcomes in the critically injured trauma patient and the effect of implementing standard operating procedures. Ann Surg (2012) 2.07

A paradoxical role for myeloid-derived suppressor cells in sepsis and trauma. Mol Med (2010) 2.06

Stratification is the key: inflammatory biomarkers accurately direct immunomodulatory therapy in experimental sepsis. Crit Care Med (2009) 2.04

Long-term posttraumatic stress symptoms vary inversely with early opiate dosing in children recovering from serious burns: effects durable at 4 years. J Trauma Acute Care Surg (2014) 2.03

Clinical microfluidics for neutrophil genomics and proteomics. Nat Med (2010) 2.02

Ultra-high-efficiency strong cation exchange LC/RPLC/MS/MS for high dynamic range characterization of the human plasma proteome. Anal Chem (2004) 2.00

An estimator for treatment comparisons among survivors in randomized trials. Biometrics (2005) 2.00

B cells enhance early innate immune responses during bacterial sepsis. J Exp Med (2011) 1.99

Comparative proteome analyses of human plasma following in vivo lipopolysaccharide administration using multidimensional separations coupled with tandem mass spectrometry. Proteomics (2005) 1.94

Cecal ligation and puncture-induced murine sepsis does not cause lung injury. Crit Care Med (2013) 1.94

Development of a genomic metric that can be rapidly used to predict clinical outcome in severely injured trauma patients. Crit Care Med (2013) 1.94

Defective innate immunity predisposes murine neonates to poor sepsis outcome but is reversed by TLR agonists. Blood (2008) 1.94

Mechanisms of mortality in early and late sepsis. Infect Immun (2006) 1.88

Increased natural CD4+CD25+ regulatory T cells and their suppressor activity do not contribute to mortality in murine polymicrobial sepsis. J Immunol (2006) 1.86

Cell-specific expression and pathway analyses reveal alterations in trauma-related human T cell and monocyte pathways. Proc Natl Acad Sci U S A (2006) 1.82

Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods. J Clin Endocrinol Metab (2004) 1.81